Shruti's Patents

Shruti has 33 patents to her credit (Canada, India and PCT filings). See full list below ...

Shruti uses strategic QBD to improve R&D productivity as well as business resilience-

Shruti's Formulation Development Expertise-

​Shruti has led path-breaking drug product development programs such as Complex Generics, Specialty Pharmaceuticals, Medical Devices, Nanotechnology-based and Targeted Drug Delivery Systems. 

Some of the cutting-edge formulation projects Shruti spearheads are:​ Dermatologicals, Ophthalmics, MUPS, Nasal gels, Dry powder inhaler capsules, Dry powder inhaler device, Effervescent & Chewable tablets, ODT, Oral rehydration salts, taste-masked pediatric syrups, Large volume parenterals, 3D Printed formulations, Nanotech-based time-release drug delivery, Colon-targeted dosage forms.
​
​Shruti integrates her proficiency in patient-centric product design, patent evaluation, QbD, Agile and Kaizen to improve pharmaceutical R&D processes, productivity and profitability. Her mantra is to shorten development timelines, build lean processes and launch products fast-to-market. 
​
Besides leading formulation programs, Shruti specializes in Continuous Improvement for R&D, designing state-of-the-art R&D facility, pilot plant, manufacturing sites and testing labs, Quality management systems, Improving R&D productivity and Mistake-proofing processes.  More >>
Shruti has received numerous industry awards such as- Young Scientist Award, IDMA Research Awards, DSIR (Department of Scientific and Industrial Research Govt. of India) Scholarship etc.
​Shruti is an Inventor to 33 patents (Canada, India and PCT filings).​ Some of them are:
  • CA 2730665 Dosage Form Containing Statin, published 3rd January 2017
  • WO 2010/006451 Dosage form containing a statin, published 21st January 2010.
  • CA 2637977 Dosage form containing a statin, published 15th January 2010
  • Modified release mucoadhesive formulation of Clopidogrel bisulphate (Appl 2162/ MUM/2012).
  • Novel pharmaceutical composition of Argatroban (Appl 2713/ MUM/ 2011).
  • Novel formulations of Tetrabenazine (Appl 2716/ MUM/ 2011).
  • Novel composition of Cefetamet pivoxil hydrochloride tablet (Appl 2221/ MUM/2011).
  • Novel formulation of Dronedarone hydrochloride (Appl 2715/ MUM/ 2011).
  • Novel composition of Lacosamide (Appl 2714/ MUM/ 2011).
  • Novel modified release composition of Cefdinir (Appl 2901/ MUM/ 2011), granted 10th May 2013
  • Modified release composition of Cefpodoxime proxetil (Appl 2902 / MUM/ 2011), granted 10th May 2013
  • A pharmaceutical composition containing cyclooxygenase inhibitor substance for oral administration. (Appl 883/ MUM/ 2004, filed 2004-08-16), granted 2007-03-16. 
  • IN2004MU00317A A process for the preparation of pharmaceutical composition containing cyclooxygenase inhibitor substance for oral administration. (Appl 317 /MUM / 2004, filed 2004-03-15) granted 2006-09-29.  
  • A process for preparation of pharmaceutical composition containing non-steroidal  anti-inflammatory substance. (Appl 1097 / MUM/ 2003, filed 2003-10-20) granted 2005-06-10. 
  • A pharmaceutical composition containing anti- diabetic substance for oral administration (Appl 882/ MUM/ 2004, filed 2004-08-16) granted 2007-03-16. 
  • A process for preparation of a pharmaceutical composition containing anti- diabetes substances for oral administration (Appl 541 /MUM/ 2004, filed 2004-05-11) granted 2007-06-08. 
  • A process for preparation of pharmaceutical composition containing a non-steroidal anti-inflammatory drug (Appl 834/ MUM/ 2000, filed 200-09-13) granted 2005-07-01. 
  • IN189626 A process for preparation of stable pharmaceutical composition containing anti-bacterial substance and microorganisms (Appl 447/ MUM / 2001, filed 2001-05-10) granted 2003-03-29. 
  • IN189627 A process for preparation of pharmaceutical composition containing a gluco-corticoid (Appl 425/ MUM/ 2001, filed 2001-05-04), granted 2003-03-29.

and others...
If you would like more details about these and about any aspect of Shruti's work, then feel free to contact her for more information.